8A-METHYL-TRANS-DECAHYDRO-NAPHTHALEN-4A-YL-ACETATE
Compound with spectra: 4 NMR
| SpectraBase Compound ID | Inr00HzQqR8 |
|---|---|
| InChI | InChI=1S/C13H22O2/c1-11(14)15-13-9-5-3-7-12(13,2)8-4-6-10-13/h3-10H2,1-2H3 |
| InChIKey | DHUZAYFRDSWPSF-UHFFFAOYSA-N |
| Mol Weight | 210.32 g/mol |
| Molecular Formula | C13H22O2 |
| Exact Mass | 210.16198 g/mol |
| Copyright | Copyright © 2002-2024 Wiley-VCH Verlag GmbH & Co. KGaA. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
| Copyright | Copyright © 2002-2024 Wiley-VCH Verlag GmbH & Co. KGaA. All Rights Reserved. |
|---|---|
| Solvent | Neat liquid |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
- 8A-METHYL-CIS-DECAHYDRO-NAPHTHALEN-4A-YL-ACETATE
- 9a-Acetoxy-10-methyl-trans-decalin
- 9b-Acetoxy-10-methyl-cis-decalin
(1S,2S)-1,2-Epoxy-1-hydroxymethyl-2-(4-pentenyl)-cyclododecane
5,5-Dimethyl-1-oxaspiro[5.5]undecan-2-ol
6-Butyl-1-oxaspiro[4.4]nonan-2-one
6-Pentyl-1-oxaspio[4.4]nonan-2-one
1-Benzoxepin-2(3H)-one, octahydro-5a-methyl-, trans-
Spiro[4.5]decan-6-ol, 7-chloro-, acetate, trans-
Spiro[4.5]decan-6-ol, 7-chloro-, acetate, cis-
1-Oxaspiro[4.6]undecan-2-one, 6,11-dimethyl-, (5.alpha.,6.alpha.,11.beta.)-(.+-.)-
(1R*,5R*,8R*)-8-Methylbicyclo[6.3.0]undecan-1,5-diol
(1R*,5S*,8R*)-8-Methylbicyclo[6.3.0]undecan-1,5-diol
| Title | Journal or Book | Year |
|---|---|---|
| Carbon-13 N.M.R. studies of 5α- and 5β-Cholestan-5-ols and analogous 8a-Methyl-trans- and cis-decahydronaphthalen-4a-ols | Australian Journal of Chemistry | 1981 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.